Brokerages Set Oscar Health, Inc. (NYSE:OSCR) PT at $20.78

Oscar Health, Inc. (NYSE:OSCR) has received an average recommendation of “Hold” from the twelve research firms that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $20.7778.

A number of equities analysts recently weighed in on OSCR shares. Zacks Research cut shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 5th. UBS Group increased their price objective on shares of Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Jefferies Financial Group raised shares of Oscar Health from an “underperform” rating to a “hold” rating and increased their price objective for the stock from $10.00 to $16.00 in a research report on Monday, April 20th. Wells Fargo & Company set a $20.00 price objective on shares of Oscar Health and gave the stock an “equal weight” rating in a research report on Thursday, June 4th. Finally, Robert W. Baird increased their target price on shares of Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th.

Insider Activity at Oscar Health

In related news, Director Mario Schlosser sold 147,500 shares of Oscar Health stock in a transaction on Tuesday, June 23rd. The shares were sold at an average price of $29.38, for a total transaction of $4,333,550.00. Following the sale, the director directly owned 1,360,866 shares in the company, valued at $39,982,243.08. This trade represents a 9.78% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Adam Mcananey sold 9,859 shares of Oscar Health stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $216,306.46. Following the sale, the insider owned 218,096 shares in the company, valued at $4,785,026.24. This represents a 4.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 1,217,160 shares of company stock worth $34,471,090 over the last 90 days. 24.39% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Oscar Health

Several hedge funds and other institutional investors have recently bought and sold shares of OSCR. BIT Capital GmbH raised its stake in Oscar Health by 545.0% during the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock worth $88,897,000 after acquiring an additional 5,227,152 shares in the last quarter. American Century Companies Inc. raised its stake in Oscar Health by 89.0% during the 3rd quarter. American Century Companies Inc. now owns 5,298,340 shares of the company’s stock worth $100,298,000 after acquiring an additional 2,495,691 shares in the last quarter. Farallon Capital Management LLC raised its stake in Oscar Health by 146.5% during the 3rd quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company’s stock worth $68,886,000 after acquiring an additional 2,163,000 shares in the last quarter. Morgan Stanley raised its stake in Oscar Health by 42.8% during the 4th quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock worth $97,918,000 after acquiring an additional 2,043,758 shares in the last quarter. Finally, Bank of America Corp DE raised its stake in Oscar Health by 205.1% during the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock worth $32,808,000 after acquiring an additional 1,922,732 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Stock Performance

Oscar Health stock opened at $28.64 on Friday. The firm has a 50 day simple moving average of $22.74 and a 200-day simple moving average of $17.28. Oscar Health has a 1-year low of $10.69 and a 1-year high of $30.38. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The stock has a market cap of $8.63 billion, a price-to-earnings ratio of -48.54, a price-to-earnings-growth ratio of 2.04 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.96. The firm had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The firm’s quarterly revenue was up 52.6% on a year-over-year basis. During the same quarter last year, the company posted $0.92 EPS. On average, analysts expect that Oscar Health will post 0.47 EPS for the current year.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.